Editorial: aminosalicylates in Crohn’s disease-prevalence, risks, costs and time to re-assess?

Related Articles

Editorial: aminosalicylates in Crohn’s disease-prevalence, risks, costs and time to re-assess?

Aliment Pharmacol Ther. 2018 Aug;48(4):487-488

Authors: Mansfield J, MacDougall L

PMID: 30588694 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/30588694?dopt=Abstract